lpo levels Search Results


lpo protein levels  (Human Protein Atlas)
86
Human Protein Atlas lpo protein levels
Genetic and expression evidence of the <t>LPO</t> lactoperoxidase gene in COVID-19 severity. (A) Lollipop diagram of LPO showing the 6 coding variants identified in our COVID-19 patient cohort (green = missense, black = truncating). The diagram was obtained using the MutationMapper tool on the cBioPortal for Cancer Genomics <t>(</t> <t>https://www.cbioportal.org/mutation_mapper</t> ). (B) Normalized LPO mRNA expression levels in patients admitted to ICU and those hospitalised, as retrieved from RNA-seq data on patients' PBMCs. Each dot represents an individual sample; boxplots show the median, interquartile range, and distribution. (C) Meta-analysis of the association between the common rs77996252 SNP in LPO and COVID-19 severity in the RGC database. The Forest plot visualises the individual study ORs, 95% CIs, and the pooled OR. The x-axis is displayed on a log10 scale. Each study's OR, 95% CI, and p-value were displayed alongside the plot. (D) Meta-analysis of the association between rare variants in LPO and COVID-19 severity. The Forest plot visualises the individual study ORs, 95% CIs, and the pooled OR. The x-axis is displayed on a log10 scale. Each study's OR, 95% CI, and p-value were displayed alongside the plot. Data include European cohorts (UK Biobank and Geisinger Health System) from the RGC database and our own Italian cohort. (E) Differential LPO expression in disease vs healthy individuals by protein extension assay. Data were retrieved from the Human Protein Atlas. Each dot represents a disease. The x-axis indicates the p-value of significance whereas the y-axis reports the log2(fold-change) in the expression of LPO protein in diseased patients vs healthy controls.
Lpo Protein Levels, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lpo+levels/levels+lpo+protein/pmc12809084-389-23-30
Average 86 stars, based on 1 article reviews
lpo protein levels - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

Image Search Results


Genetic and expression evidence of the LPO lactoperoxidase gene in COVID-19 severity. (A) Lollipop diagram of LPO showing the 6 coding variants identified in our COVID-19 patient cohort (green = missense, black = truncating). The diagram was obtained using the MutationMapper tool on the cBioPortal for Cancer Genomics ( https://www.cbioportal.org/mutation_mapper ). (B) Normalized LPO mRNA expression levels in patients admitted to ICU and those hospitalised, as retrieved from RNA-seq data on patients' PBMCs. Each dot represents an individual sample; boxplots show the median, interquartile range, and distribution. (C) Meta-analysis of the association between the common rs77996252 SNP in LPO and COVID-19 severity in the RGC database. The Forest plot visualises the individual study ORs, 95% CIs, and the pooled OR. The x-axis is displayed on a log10 scale. Each study's OR, 95% CI, and p-value were displayed alongside the plot. (D) Meta-analysis of the association between rare variants in LPO and COVID-19 severity. The Forest plot visualises the individual study ORs, 95% CIs, and the pooled OR. The x-axis is displayed on a log10 scale. Each study's OR, 95% CI, and p-value were displayed alongside the plot. Data include European cohorts (UK Biobank and Geisinger Health System) from the RGC database and our own Italian cohort. (E) Differential LPO expression in disease vs healthy individuals by protein extension assay. Data were retrieved from the Human Protein Atlas. Each dot represents a disease. The x-axis indicates the p-value of significance whereas the y-axis reports the log2(fold-change) in the expression of LPO protein in diseased patients vs healthy controls.

Journal: eBioMedicine

Article Title: Multi-omics identifies oxidative stress, prothrombotic pathways, and lactoperoxidase variants as key factors in COVID-19 severity

doi: 10.1016/j.ebiom.2025.106111

Figure Lengend Snippet: Genetic and expression evidence of the LPO lactoperoxidase gene in COVID-19 severity. (A) Lollipop diagram of LPO showing the 6 coding variants identified in our COVID-19 patient cohort (green = missense, black = truncating). The diagram was obtained using the MutationMapper tool on the cBioPortal for Cancer Genomics ( https://www.cbioportal.org/mutation_mapper ). (B) Normalized LPO mRNA expression levels in patients admitted to ICU and those hospitalised, as retrieved from RNA-seq data on patients' PBMCs. Each dot represents an individual sample; boxplots show the median, interquartile range, and distribution. (C) Meta-analysis of the association between the common rs77996252 SNP in LPO and COVID-19 severity in the RGC database. The Forest plot visualises the individual study ORs, 95% CIs, and the pooled OR. The x-axis is displayed on a log10 scale. Each study's OR, 95% CI, and p-value were displayed alongside the plot. (D) Meta-analysis of the association between rare variants in LPO and COVID-19 severity. The Forest plot visualises the individual study ORs, 95% CIs, and the pooled OR. The x-axis is displayed on a log10 scale. Each study's OR, 95% CI, and p-value were displayed alongside the plot. Data include European cohorts (UK Biobank and Geisinger Health System) from the RGC database and our own Italian cohort. (E) Differential LPO expression in disease vs healthy individuals by protein extension assay. Data were retrieved from the Human Protein Atlas. Each dot represents a disease. The x-axis indicates the p-value of significance whereas the y-axis reports the log2(fold-change) in the expression of LPO protein in diseased patients vs healthy controls.

Article Snippet: Finally, to better understand whether and how LPO levels are altered in COVID-19 or other disease conditions, we explored publicly available data on LPO protein levels in blood from the Human Protein Atlas ( https://www.proteinatlas.org/ENSG00000167419-LPO/blood ).

Techniques: Expressing, Mutagenesis, RNA Sequencing